Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Avenue Therapeutics, Inc. (ATXI)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 16,750,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Avenue Therapeutics is a pharmaceutical company that develop and commercialize its product principally for use in the acute/intensive care hospital setting. Co.'s product candidate is intravenous (IV) Tramadol, for the treatment of post-operative acute pain. Tramadol, a synthetic dual-acting opioid, is a centrally acting analgesic with weak opioid agonist properties. It also works via the inhibition of serotonin and noradrenaline re-uptake and blocking nociceptive impulses at the spinal level. Co. has completed a pharmacokinetic study for IV Tramadol in healthy volunteers. Co. also has initiated a Phase 3 development program of IV Tramadol for the management of post-operative pain.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 767,085 767,085
Total Buy Value $0 $0 $552,301 $552,301
Total People Bought 0 0 2 2
Total Buy Transactions 0 0 2 2
Total Shares Sold 0 617,000 617,000 1,005,888
Total Sell Value $0 $86,560 $86,560 $3,086,442
Total People Sold 0 1 1 2
Total Sell Transactions 0 2 2 3
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 11
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Vazzano Joseph Walter Chief Financial Officer   •       –      –    2021-09-15 4 S $1.62 $11,599 D/D (7,160) 65,252     -
   Herskowitz Neil Director   –       •      –    2021-05-06 4 B $3.99 $9,975 D/D 2,500 134,724 2.39     -
   Vazzano Joseph Walter Chief Financial Officer   •       –      –    2020-08-20 4 S $12.13 $46,579 D/D (3,840) 57,412     -
   Kranzler Jay D Director   –       •      –    2020-06-16 4 A $0.00 $0 D/D 10,000 84,663     -
   Herskowitz Neil Director   –       •      –    2020-06-16 4 A $0.00 $0 D/D 10,000 132,224     -
   Vazzano Joseph Walter Chief Financial Officer   •       –      –    2020-03-10 4 B $7.94 $14,999 D/D 1,889 61,252 2.74     -
   Vazzano Joseph Walter Chief Financial Officer   •       –      –    2020-03-09 4 B $7.97 $11,983 D/D 1,500 59,363 2.74     -
   Herskowitz Neil Director   –       •      –    2020-02-27 4 B $8.20 $19,680 D/D 2,400 122,224 2.39     -
   Herskowitz Neil Director   –       •      –    2020-02-26 4 B $8.73 $1,406 D/D 161 119,824 2.31     -
   Herskowitz Neil Director   –       •      –    2020-02-25 4 B $9.31 $93,100 D/D 10,000 119,663 2.39     -
   Vazzano Joseph Walter Chief Financial Officer   •       –      –    2020-02-25 4 B $9.09 $10,908 D/D 1,200 57,863 2.74     -

  11 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed